Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

NCT02041234 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type II Diabetes in Subjects BMI 27 to 32

Interventions

PROCEDURE: Roux-en-Y Gastric Bypass (RYGB)
DRUG: Incretin analogues
DRUG: Xenical
DRUG: SGLT2 inhibitors
DRUG: DPP-4 Inhibitors

Sponsor

Khoo Teck Puat Hospital